Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat

被引:85
作者
Silvestrini, G
Ballanti, P
Patacchioli, F
Leopizzi, M
Gualtieri, N
Monnazzi, P
Tremante, E
Sardella, D
Bonucci, E
机构
[1] Policlin Umberto 1, Dept Expt Med & Pathol, Sez Anat Patol, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Rome, Italy
关键词
D O I
10.1007/s10735-004-3839-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Osteoprotegerin (OPG) and the receptor activator of nuclear factor (NF)-kB ligand (RANKL) are key regulators of osteoclastogenesis. The present study had the main aim of showing the localization of OPG and RANKL mRNA and protein in serial sections of the rat femurs and tibiae by immunohistochemistry (IHC) and in situ hybridization (ISH). The main results were: (1) OPG and RANKL mRNA and protein were co-localized in the same cell types, (2) maturative/hypertrophic chondrocytes, osteoblasts, lining cells, periosteal cells and early osteocytes were stained by both IHC and ISH, (3) OPG and RANKL proteins were mainly located in Golgi areas, and the ISH reaction was especially visible in active osteoblasts, (4) immunolabeling was often concentrated into cytoplasmic vacuoles of otherwise negative proliferative chondrocytes; IHC and ISH labeling increased from proliferative to maturative/hypertrophic chondrocytes, (5) the newly laid down bone matrix, cartilage-bone interfaces, cement lines, and trabecular borders showed light OPG and RANKL immunolabeling, (6) about 70% of secondary metaphyseal bone osteocytes showed OPG and RANKL protein expression; most of them were ISH-negative, (7) osteoclasts were mostly unstained by IHC and variably labeled by ISH. The co-expression of OPG and RANKL in the same bone cell types confirms their strictly coupled action in the regulation of bone metabolism.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 21 条
[1]
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]
Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation [J].
Atkins, GJ ;
Haynes, DR ;
Geary, SM ;
Loric, M ;
Crotti, TN ;
Findlay, DM .
BONE, 2000, 26 (06) :653-661
[3]
Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro [J].
Chikatsu, N ;
Takeuchi, Y ;
Fukumoto, S ;
Yano, K ;
Fujita, N ;
Tsuruo, T ;
Fujita, T .
ENDOCRINE JOURNAL, 2002, 49 (04) :439-447
[4]
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques [J].
Dhore, CR ;
Cleutjens, JPM ;
Lutgens, E ;
Cleutjens, KBJM ;
Geusens, PPM ;
Kitslaar, PJEHM ;
Tordoir, JHM ;
Spronk, HMH ;
Vermeer, C ;
Daemen, MJAP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :1998-2003
[5]
Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene [J].
Enomoto, H ;
Shiojiri, S ;
Hoshi, K ;
Furuichi, T ;
Fukuyama, R ;
Yoshida, CA ;
Kanatani, N ;
Nakamura, R ;
Mizuno, A ;
Zanma, A ;
Yano, K ;
Yasuda, H ;
Higashio, K ;
Takada, K ;
Komori, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23971-23977
[6]
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12
[7]
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand [J].
Hsu, HL ;
Lacey, DL ;
Dunstan, CR ;
Solovyev, I ;
Colombero, A ;
Timms, E ;
Tan, HL ;
Elliott, G ;
Kelley, MJ ;
Sarosi, I ;
Wang, L ;
Xia, XZ ;
Elliott, R ;
Chiu, L ;
Black, T ;
Scully, S ;
Capparelli, C ;
Morony, S ;
Shimamoto, G ;
Bass, MB ;
Boyle, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3540-3545
[8]
Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones [J].
Ikeda, T ;
Utsuyama, M ;
Hirokawa, K .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (08) :1416-1425
[9]
Localization of RANKL (Receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues [J].
Kartsogiannis, V ;
Zhou, H ;
Horwood, NJ ;
Thomas, RJ ;
Hards, DK ;
Quinn, JMW ;
Niforas, P ;
Ng, KW ;
Martin, TJ ;
Gillespie, MT .
BONE, 1999, 25 (05) :525-534
[10]
Komuro H, 2001, ARTHRITIS RHEUM, V44, P2768, DOI 10.1002/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO